Karen Valentine's Net Worth
$2.1 Million
Who is Karen Valentine?
Karen Valentine has an estimated net worth of $2.1 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, and ANTIGENICS INC /DE/.
SEC CIK
Karen Valentine's CIK is 0001437152
Past Insider Trading and Trends
2020 was Karen Valentine's most active year for acquiring shares with 18 total transactions. Karen Valentine's most active month to acquire stocks was the month of December. 2020 was Karen Valentine's most active year for disposing of shares, totalling 34 transactions. Karen Valentine's most active month to dispose stocks was the month of January. 2018 saw Karen Valentine paying a total of $978,297.50 for 318,485 shares, this is the most they've acquired in one year. In 2020 Karen Valentine cashed out on 152,628 shares for a total of $2,713,004.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$22.74 | -$386,628.13 |
0
|
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
$25.60 | -$501,408.58 |
0
|
Scheduled
|
May 5 - May 6
| ||
Form 4
|
—
|
0
|
$25.82 | -$11,452.00 |
0
|
Scheduled
|
Apr 27
| ||
Form 4
|
—
|
0
|
$22.58 | -$17,476.59 |
0
|
Scheduled
|
Apr 20
| ||
Form 4
|
—
|
0
|
$22.89 | -$120,649.58 |
0
|
Scheduled
|
Apr 16 - Apr 17
| ||
Form 4
|
—
|
0
|
$21.89 | -$16,673.64 |
0
|
Scheduled
|
Apr 9
| ||
Form 4
|
—
|
0
|
$20.40 | -$14,358.33 |
0
|
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
$22.85 | -$145,918.66 |
0
|
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4/A
|
—
|
0
|
$22.68 | -$516,503.46 |
0
|
Scheduled
|
Feb 10 - Feb 11
| ||
Form 4
|
—
|
0
|
$22.79 | -$511,434.46 |
0
|
Feb 10 - Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ANTIGENICS INC /DE/ (AGEN) Snapshot price: $4.95
Chief Legal Officer and GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +19.36% | 16.47K |
$3.53 | $60,196.97 | 101.52K |
Oct 9 - Dec 12
| |||
Form 4
| +48.14% | 32.88K |
$3.39 | $111,453.03 | 85.06K |
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4/A
| +32.51% | 16.75K |
$4.15 | $69,529.10 | 68.29K |
Apr 26
| |||
Form 4/A
| +63.82% | 32.89K |
$4.15 | $136,493.50 | 68.29K |
Apr 26
| |||
Form 4
|
∞
| 16.59K |
$4.15 | $68,836.05 | 16.59K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| -5.24% | -2.85K |
$3.50 | -$9,975.00 | 51.53K |
Scheduled
|
Jan 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +1.44% | 417 |
$4.35 | $1,813.95 | 29.38K |
Jan 28
| |||
Form 4
| +1.46% | 417 |
$4.42 | $1,843.14 | 28.97K |
Oct 26
| |||
Form 4
| +9.22% | 2.41K |
—
|
—
| 28.55K |
Sep 12
| |||
Form 4
| +1.62% | 416 |
$4.61 | $1,917.76 | 26.14K |
Jul 26
| |||
Form 4
| +27.74% | 5.59K |
$5.13 | $30,528.17 | 25.72K |
Scheduled
|
Jun 19 - Jun 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +2.11% | 417 |
$6.43 | $2,681.31 | 20.14K |
Apr 26
| |||
Form 4
| +17.27% | 2.9K |
$5.31 | $15,420.24 | 19.72K |
Mar 15
| |||
Form 4
| +2.54% | 417 |
$2.76 | $1,150.92 | 16.82K |
Jan 26
| |||
Form 4
| +1,276.91% | 15.21K |
$2.17 | $33,001.36 | 16.4K |
Jan 3
| |||
Form 4
| -90.29% | -11.07K |
$2.02 | -$22,418.65 | 1.19K |
Dec 27 - Dec 29
| |||
Form 4
| -25.20% | -4.13K |
$2.22 | -$9,168.77 | 12.27K |
Dec 21 - Dec 23
| |||
Form 4
| +2.60% | 416 |
$2.70 | $1,123.20 | 16.4K |
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
| +3.60% | 3.33K |
$0.55 | $1,833.70 | 95.9K |
Sep 12
| |||
Form 4
| +2.78% | 2.5K |
$0.79 | $1,975.00 | 92.57K |
Jul 26
| |||
Form 4
| +2.85% | 2.5K |
$0.92 | $2,300.00 | 90.07K |
Apr 26
| |||
Form 4
| +11.05% | 8.71K |
$0.98 | $8,537.76 | 87.57K |
Mar 9
| |||
Form 4
| +3.27% | 2.5K |
$0.95 | $2,375.00 | 78.86K |
Jan 26
| |||
Form 4
| +35.16% | 19.86K |
$0.94 | $18,673.10 | 76.36K |
Jan 18 - Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
$0.98 |
—
| 56.49K |
Scheduled
|
Oct 26 - Oct 27
| ||
Form 4
|
—
|
0
|
$0.92 | $53.66 | 56.49K |
Sep 10 - Sep 14
| |||
Form 4
| +4.63% | 2.5K |
$0.79 | $1,975.00 | 56.49K |
Jul 26
| |||
Form 4
| +4.86% | 2.5K |
$1.19 | $2,975.00 | 53.99K |
Apr 26
| |||
Form 4
| -36.06% | -29.04K |
$0.76 | -$22,005.75 | 51.49K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4/A
|
—
|
0
|
$0.88 | $4,370.57 | 80.53K |
Scheduled
|
Jan 19 - Jan 20
| ||
Form 4
| +232.93% | 187.58K |
$0.88 | $164,449.63 | 80.53K |
Scheduled
|
Jan 19 - Jan 20
| ||
Form 4
| +2.86% | 2.24K |
$2.36 | $5,457.84 | 80.53K |
Sep 10 - Sep 11
| |||
Form 4
| +125.79% | 43.62K |
$1.67 | -$39,443.28 | 78.29K |
Jul 14 - Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
| +92.15% | 22.59K |
$0.46 |
—
| 34.67K |
Jan 10
| |||
Form 4
| +15.19% | 3.23K |
$0.48 | -$948.96 | 24.51K |
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
| +110.59% | 11.18K |
$1.76 | -$9,152.00 | 21.28K |
Jul 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |